Birchview Capital, LP HROW — HARROW HEALTH INC

Ownership history in Birchview Capital, LP  ·  28 quarters on record

AI Ownership Summary

Birchview Capital, LP reported HARROW HEALTH INC (HROW) in 28 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 2.9% in 2024 Q2. The latest visible filing shows HROW at 0.98% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this HROW ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Birchview Capital, LP's position in HARROW HEALTH INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

HROW was reported at 0.98% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.9% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

HROW stock page Birchview Capital, LP fund profile Birchview Capital, LP full holdings
How Birchview Capital, LP held HROW — position size vs. price
% of Fund (quarterly)    HROW price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 15.0% -28.0% ✅ 34,000 -6,000 -15.0% 0.98% $1.7M 2026-02-14 (Est.) $47.69
2025 Q3 REDUCED 33.3% +5.3% ❌ 40,000 -20,000 -33.3% 1.46% $1.9M 2025-11-13 $37.89
2025 Q2 REDUCED 17.7% +58.5% ❌ 60,000 -12,910 -17.7% 1.82% $1.8M 2025-08-14 $40.01
2025 Q1 UNCHANGED — — — 72,910 — 0% 1.68% $1.9M 2025-05-15 $25.62
2024 Q4 UNCHANGED — — — 72,910 — 0% 1.99% $2.4M 2025-02-14 $30.42
2024 Q3 REDUCED 51.4% -25.7% ✅ 72,910 -77,090 -51.4% 2.84% $3.3M 2024-11-14 $42.86
2024 Q2 UNCHANGED — — — 150,000 — 0% 2.90% $3.1M 2024-08-13 $37.85
2024 Q1 UNCHANGED — — — 150,000 — 0% 1.62% $2.0M 2024-05-14 $16.24
2023 Q4 UNCHANGED — — — 150,000 — 0% 1.32% $1.7M 2024-02-14 $11.49
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding HROW

As of 2026 Q1 — sorted by position size

Blackhawk Capital Partners, LLC 3Y 7Y 2.23% Westside Investment Management, Inc. 3Y 7Y 1.0% Walleye Partners, LLC 0.58% Ahara Advisors LLC 0.57% WOODMONT INVESTMENT COUNSEL LLC 3Y 7Y 0.24% LJI Wealth Management, LLC 0.22% CORRADO ADVISORS, LLC 3Y 7Y 0.14% EQUITABLE TRUST CO 3Y 7Y 0.07% ADVOCATE GROUP LLC 3Y 0.05% Patriot Financial Group Insurance Agency, LLC 3Y 7Y 0.03%

FAQ About Birchview Capital, LP and HROW

These are the practical questions this page is built to answer before you even open the full history table.

How long has Birchview Capital, LP reported owning HROW?

Birchview Capital, LP reported HROW across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported HROW position in Birchview Capital, LP's portfolio?

The largest reported portfolio weight for HROW was 2.90% in 2024 Q2.

What is the latest reported HROW position on this page?

The most recent filing on this page is 2025 Q4, when Birchview Capital, LP reported 34,000 shares, equal to 0.98% of portfolio, with an estimated market value of $1.7M.

What does the chart on this HROW ownership page compare?

The chart compares Birchview Capital, LP's quarterly HROW portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Birchview Capital, LP time their HROW position?

Based on 13F filing dates vs. subsequent HROW price moves, Birchview Capital, LP correctly timed 4 out of 5 reported position changes (80%). The annualised alpha on HROW relative to SPY over the holding period was +23.0%.

← Back to Birchview Capital, LP Holdings